Publication:
Ischaemic stroke complicating primary percutaneous coronary intervention in patients with ST elevation myocardial infarction

dc.contributor.authorsErgelen, Mehmet; Gorgulu, Sevket; Uyarel, Huseyin; Norgaz, Tugrul; Ayhan, Erkan; Akkaya, Emre; Ergelen, Rabia; Cicek, Gokhan; Ugur, Murat; Soylu, Ozer; Tezel, Tuna; Yekeler, Ibrahim
dc.date.accessioned2022-03-12T17:46:58Z
dc.date.accessioned2026-01-11T07:59:48Z
dc.date.available2022-03-12T17:46:58Z
dc.date.issued2009
dc.description.abstractObjective - We sought to determine the in-hospital incidence and predictors of ischaemic stroke in patients with ST elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). Methods - We reviewed 2638 consecutive patients undergoing 2722 pimary PCI procedures for STEMI during in-hospital stay. Stroke was defined as any new focal neurological deficit lasting >= 24 h, occurring anytime during or after PCI until discharge. Patients with haemorrhagic stroke were excluded. Clinical characteristics and in-hospital outcome were analysed regarding ischaemic stroke in patients undergoing primary PCI. Results - Ischaemic stroke was observed in 20 of the 2722 procedures, an incidence of 0.73%. Patients with ischaemic stroke were older than patients without stroke (mean age 67 +/- 9.6 vs. 56.6 +/- 11.8, P < 0.001). Compared to patients without stroke, female gender, diabetes and hypertension were more prevalent in patients with stroke. Ischaemic stroke was found to be a powerful independent predictor of in-hospital cardiovascular mortality (odds ratio [OR] 6.32, 1.15-34.7; P < 0.001). Left ventricular ejection fraction (LVEF) < 35% (OR 3.13, P = 0.04), contrast-induced nephropathy (OR 2.91, P = 0.04) and tirofiban use (OR 0.23, P = 0.02) were the independent predictors for in-hospital ischaemic stroke. Conclusions - The present Study shows that the incidence of ischaemic stroke in patients undergoing PCI for STEMI is higher and ischaemic stroke increases in-hospital mortality in these patients. Moreover, LVEF < 35% and contrast-induced nephropathy were independent predictors of ischaemic stroke, whereas tirofiban use demonstrated a protective effect to this potentially catastrophic complication.
dc.identifier.doi10.2143/AC.64.6.2044735
dc.identifier.eissn1784-973X
dc.identifier.issn0001-5385
dc.identifier.pubmed20128147
dc.identifier.urihttps://hdl.handle.net/11424/229621
dc.identifier.wosWOS:000273486700003
dc.language.isoeng
dc.publisherTAYLOR & FRANCIS LTD
dc.relation.ispartofACTA CARDIOLOGICA
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectST elevation myocardial infarction
dc.subjectprimary percutaneous coronary intervention
dc.subjectischaemic stroke
dc.subjectprognosis
dc.subjectprimary angioplasty
dc.subjecttirofiban
dc.subjectmortality
dc.subjectCLINICAL FINDINGS
dc.subjectGLOBAL REGISTRY
dc.subjectRISK-FACTORS
dc.subjectTHROMBOLYSIS
dc.subjectANGIOPLASTY
dc.subjectMORTALITY
dc.subjectOUTCOMES
dc.subjectEVENTS
dc.subjectREVASCULARIZATION
dc.subjectMANAGEMENT
dc.titleIschaemic stroke complicating primary percutaneous coronary intervention in patients with ST elevation myocardial infarction
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage734
oaire.citation.issue6
oaire.citation.startPage729
oaire.citation.titleACTA CARDIOLOGICA
oaire.citation.volume64

Files